Clinical Trial Update: Tezosentan in the Treatment of Acute Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Tezosentan for acute heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensation of Chronic Heart Failure
• Heart Failure
• New-onset Heart Failure

Drugs mentioned

• Tezosentan (tezosentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Acute Heart Failure, Acute Decompensation of Chronic Heart Failure | Phase 3 | Status: COMPLETED